Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroblastoma Study NB97
NCT00017225Phase 2Completed
- Sponsor
- German Society for Pediatric Oncology and Hematology
- Start
- May 1997
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 2 trial of melphalan, etoposide, carboplatin, cyclophosphamide in neuroblastoma, sponsored by German Society for Pediatric Oncology and Hematology. Started May 1997; status: completed.
02
Drugs
melphalanetoposidecarboplatincyclophosphamide
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00017225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017225.